Michael Truett Tate, Chief Financial Officer at Astera Labs, Inc. (ALAB), sold 900,700 shares at $89.05 ($81.3M) on 2025-05-30, disclosed to the SEC on 2025-06-03.
Scheduled sale ($81.3M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.14 | 19,998 | $1.8M | 2.2% |
| 2 | $88.14 | 19,998 | $1.8M | 2.2% |
| 3 | $89.05 | 92,200 | $8.2M | 10.1% |
| 4 | $90.06 | 156,288 | $14.1M | 17.3% |
| 5 | $90.06 | 156,288 | $14.1M | 17.3% |
| 6 | $90.75 | 204,954 |
| $18.6M |
| 22.9% |
| 7 | $90.75 | 204,954 | $18.6M | 22.9% |
| 8 | $92.04 | 15,492 | $1.4M | 1.8% |
| 9 | $92.04 | 15,492 | $1.4M | 1.8% |
| 10 | $92.96 | 3,968 | $369K | 0.5% |
| 11 | $92.96 | 3,968 | $369K | 0.5% |
| 12 | $94.33 | 7,100 | $670K | 0.8% |
| Total | $90.31 avg | 900,700 | $81.3M | 100% |
| Filing → |
| ALAB | SELL | 2025-08-20 | $6.9M | — | Filing → |
| ALAB | SELL | 2025-08-20 | $33.0M | — | Filing → |
| ALAB | SELL | 2025-08-14 | $38.2M | — | Filing → |